Request for Covid-19 Impact Assessment of this Report
For short term treatments, Nasogastric (NG) and Nasojejunal (NJ) tubes are commonly used and are dependent on gastric emptying. These are fairly easy to insert. For any disease lasting longer than a month, Percutaneous Endoscopic Gastrotomy (PEG) or Jejunostomy should be considered. These are directly inserted surgically or endoscopically through the stomach wall. Inserting these can be difficult and one has to be extremely cautious as it can lead to complications.
Market Dynamics
Ageing actually increases the chances of a person getting Parkinson's disease or other nervous breakdowns. With percentage of population above 65+ growing at a healthy rate, the market is pegged to have an increased penetration globally. With the increasing pre-term births, rising chronic diseases such as diabetes, cancer, gastrointestinal diseases and neurological diseases and an increasing awareness among the patients about the technique will attribute to the growth of this market. Certain complications associated with these tubes like misconnections, tube dislodgement and infections may hit the growth of this market.
Market Segmentation
The market is segmented in terms of the products, stages and end-usage. In terms of products, the market is segmented into Enteral feeding pumps, tubes, administration reservoirs, giving sets and eternal syringes with more than 50% market owned by Enteral Feeding Pumps. Based on the stages, the market is divided into Pediatric and Adults. The end user market is classified into Hospitals and Ambulatory Care Units (ACU).
Regional/Geographic Analysis
The United States and Canada in North America are the major players globally followed by Europe, Asia-Pacific and then ROW. Asia Pacific and Latin America would be the major players in the years to come primarily due to the increase in population in these regions along with the rise in geriatric population.
Key Players
--> Some of the major players in the market include Abbott LaboratoriesB. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., ConMed Corporation, Cook Medical, Inc., Covidien PLC, Fresenius Se & Co., Halyard Health, Inc., Medtronic PLC, Moog, Inc. etc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...